Keyphrases
Insulin Glargine
100%
Legacy Effects
100%
Omega-3 Fatty Acids
100%
Glargine
100%
Chronic Disease Management
100%
Usual Care
100%
Pharmacist-led
100%
Cardiovascular Mortality
60%
Neutral Effects
60%
Clinical Outcomes
53%
Myocardial Infarction
40%
Cardiovascular Outcomes
40%
Physiologic
33%
Lower Limb Strength
33%
Data Extraction
33%
United States
33%
Clinical Events
33%
Goal Attainment
33%
High Cardiovascular Risk
20%
Heart Failure Hospitalization
20%
Hazard Ratio
20%
Active Treatment
20%
Health Outcomes
20%
Placebo
20%
Omega-3
20%
3-group
20%
Intervention Effect
20%
Revascularization
20%
Metabolic Control
20%
Intervention Studies
20%
Effect Study
20%
Hemoglobin A1c (HbA1c)
20%
Dysglycemia
20%
Health Impact
20%
Incident Diabetes
20%
Difference in Medians
20%
Omega-3 Fatty Acid Supplementation
20%
Placebo Groups
20%
Care Groups
20%
Clinical Follow-up
20%
Lipid Goals
16%
Retail Pharmacy
16%
Patient Outcomes
16%
Patient Satisfaction
16%
Veterans Health Administration
16%
Office Visits
16%
Community-dwelling Adults
16%
Mortality Event
16%
Patient Demographics
16%
Medication Adherence
16%
Medicine and Dentistry
Chronic Disease
100%
Disease Management
100%
Omega-3 Fatty Acid
100%
Cardiovascular System
100%
Systematic Review
100%
Insulin Glargine
100%
Mental Capacity
75%
Myocardial Infarction
33%
Apoplexy
33%
Placebo
33%
Patient Population
25%
Emergency Department
25%
Blood Pressure
25%
Glycemic
25%
Veterans Health
25%
Urgent Care
25%
Patient Satisfaction
25%
Veterans Affairs
25%
Access to Health Care
25%
Patient Care
25%
Medication Compliance
25%
Malignant Neoplasm
16%
Diabetes
16%
Care Group
16%
Revascularization
16%
Hazard Ratio
16%
Supplementation
16%
Research Design
16%
Health Outcomes
16%
Metabolic Regulation
16%
Hemoglobin A1c
16%
Dysglycemia
16%
Cardiovascular Risk
16%
Intervention Trial
16%
Congestive Heart Failure
16%
Cancer
16%
Nursing and Health Professions
Omega-3 Fatty Acid
100%
Insulin Glargine
100%
Heart Infarction
40%
Randomization
40%
Placebo
40%
Cerebrovascular Accident
40%
Malignant Neoplasm
20%
Clinical Outcome
20%
Care Group
20%
Health Outcomes
20%
Hazard Ratio
20%
Hemoglobin A1c
20%
Dysglycemia
20%
Cardiovascular Risk
20%
Supplementation
20%
Revascularization
20%
Congestive Heart Failure
20%
